×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| GUFIC BIOSCIENCES LTD. | 2096.58 | 193.24 | 2077.94 | 1.93 | 3,856 | 47.0 |
| Thyrocare Technologies Limited | 1560.56 | 192.24 | 1525.49 | 3.51 | 3850 | 44.5 |
| YATHARTH HOSPITAL & TRAUMA CAR | 2233.65 | 304.91 | 2191.55 | 3.57 | 3725 | 28.6 |
Gufic BioSciences Ltd., with Security Code 509079, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 174.8 | 177.4 | 173.0 | 195.0 | 214.8 | 201.7 | 194.9 | 202.8 | 204.1 | 207.7 |
| Expenses | 142.2 | 144.1 | 140.9 | 159.5 | 175.5 | 165.3 | 160.8 | 167.0 | 165.6 | 173.9 |
| Operating Profit | 32.6 | 33.4 | 32.1 | 35.5 | 39.4 | 36.5 | 34.2 | 35.8 | 38.6 | 33.9 |
| OPM % | 18.65% | 18.81% | 18.58% | 18.19% | 18.32% | 18.07% | 17.55% | 17.64% | 18.92% | 16.33% |
| Other Income | 0.8 | 0.8 | 0.6 | 0.9 | 0.3 | 0.4 | 0.9 | 1.3 | 0.1 | 1.9 |
| Interest | 1.6 | 2.2 | 2.9 | 4.1 | 4.5 | 3.2 | 3.6 | 4.6 | 5.2 | 4.9 |
| Depreciation | 4.6 | 4.7 | 5.9 | 4.2 | 4.3 | 4.1 | 4.3 | 4.3 | 4.3 | 4.6 |
| Profit before tax | 27.3 | 27.2 | 23.9 | 28.0 | 30.9 | 29.6 | 27.1 | 28.1 | 29.3 | 26.3 |
| Tax % | 25.9% | 25.4% | 24.3% | 26.5% | 25% | 24.7% | 26.1% | 25.8% | 25.6% | 26.5% |
| Net Profit | 20.2 | 20.3 | 18.1 | 20.6 | 23.2 | 22.3 | 20.0 | 20.9 | 21.8 | 19.3 |
| EPS in Rs | 2.09 | 2.1 | 1.87 | 2.13 | 2.39 | 2.23 | 2 | 2.08 | 2.17 | 1.93 |
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| Sales | 214.9 | 201.8 | 195.0 | 202.8 | 204.2 |
| Expenses | 175.5 | 165.3 | 160.8 | 167.0 | 165.6 |
| Operating Profit | 39.4 | 36.5 | 34.2 | 35.8 | 38.6 |
| OPM % | 18.3% | 18.1% | 17.6% | 17.6% | 18.9% |
| Other Income | 0.3 | 0.4 | 0.9 | 1.3 | 0.1 |
| Interest | 4.5 | 3.2 | 3.6 | 4.6 | 5.2 |
| Depreciation | 4.3 | 4.1 | 4.3 | 4.3 | 4.3 |
| Profit before tax | 30.9 | 29.6 | 27.1 | 28.1 | 29.3 |
| Tax % | 25% | 24.7% | 26.1% | 25.8% | 25.6% |
| Net Profit | 23.2 | 22.3 | 20.0 | 20.9 | 21.8 |
| EPS in Rs | 2 | 2 | 2 | 2 | 2 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 32% |
| 3 Years: | 26% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 39% |
| 5 Years: | 39% |
| 3 Years: | 24% |
| 1 Year: | 23% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 39% |
| 5 Years: | 39% |
| 3 Years: | 24% |
| 1 Year: | 23% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|